News

Payers grapple with expensive treatment payment options.

FDA limits packaging for this OTC medication.

Cancer treatment is becoming more personalized. Here’s how.

Oncological facilities that promote flexibility are the ones best suited to care for the needs of their patient population.

To take advantage of new devices in health studies, executives need to reinvent how data is put to work.

Optimizing the nursing function is a key design consideration to improve the patient experience and patient-reported outcomes

Tackling SDoH issues requires efforts beyond traditional healthcare roles.

The Medicare for All debate surrounds the 2020 election-but is it truly understood?

Altais, Aledade, and the California Medical Association team up to offer patient care model supported by innovative technologies

Predictive analytics in healthcare powered by artificial intelligence represents one of the most disruptive shifts. Here's how to take advantage of it.

Intervention of friends, family, and non-physician health workers is key.

Data is only valuable if it’s analyzed correctly. But that’s easier said than done.

When disaster strikes, healthcare executives must be ready to take care of those in need of emergency medical services.

Web-based application has the potential to revolutionize survey research and ultimately improve the health and well-being of many diverse populations.

HACs continue to burden the healthcare system.

Simple design considerations at St. Jude Children's Research Hospital make a positive impact on loved ones.

CareAllies, Arcadia partner to educate healthcare leaders on how health plans can provide actionable insights at the point of care.

How to cope with a rapidly-changing industry.

Findings suggest that racemic substitution for single-enantiomer drugs offers an opportunity for savings.

Fentanyl citrate and ephedrine sulfate are among the medications affected.

The move could be copied by other large employers.

Because the disease in males is rare, they have historically been excluded from clinical trials of breast cancer drugs.

FDA is evaluating risks to patients.

The technologies and consumer demands that have shaped the past-and will continue to shape the future.

An interview with the founder and president of ICER.

They must begin issuing payment by September 30.

A new survey suggests that more states-and payer organizations-are expanding telehealth coverage.

From breast cancer to prostate cancer, the state of oncology care and how it will evolve.